Immuneering Corporation (IMRX) Shareholders’ equity 2020–2023
Immuneering Corporation (IMRX) shareholders’ equity at each fiscal year-end, per SEC filings.
$90.6MFY2023 · since FY2020: -$22.5M → $90.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $90.6M | -17.5% |
| FY2022 | $109.9M | -29.6% |
| FY2021 | $156.0M | +793.8% |
| FY2020 | -$22.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice